Table 1 Patients’ characteristics
| Â | Ventricular opening (VO) | ||
|---|---|---|---|
VO | No VO | p-value | |
Mean age | 59.9 ± 14.6 | 61.3 ± 13.5 | 0.710 |
Histologies | |||
Breast cancer | 2 (14%) | 21 (19%) | Â |
NSCLC | 3 (21%) | 27 (24%) | Â |
GI tract | 2 (14%) | 21 (19%) | Â |
Melanoma | 2 (14%) | 17 (15%) | Â |
other | 5 (35%) | 25 (23%) | 0.871 |
Location | |||
Supratentorial | 10 (71%) | 82 (74%) | Â |
Infratentorial | 4 (29%) | 25 (23%) | Â |
Both | 0 | 4 (4%) | 0.701 |
RPA class | |||
1 | 3 (21%) | 23 (21%) | Â |
2 | 7 (50%) | 68 (61%) | Â |
3 | 4 (29%) | 13 (12%) | Â |
Unknown | 0 | 7 (6%) | 0.263 |
GPA | |||
 < 2 | 1(1%) | 24 (22%) |  |
2–3 | 8 (57%) | 46 (41%) |  |
 > 3 | 1 (1%) | 14(12%) |  |
Unknown | 4(29%) | 27 (24%) | 0.617 |
Number of metastases | |||
1 | 9 (64%) | 84 (76%) | Â |
2 | 5 (36%) | 20 (18%) | Â |
3 | 0 | 7 (6%) | 0.218 |
Year of treatment | |||
2009–2011 | 3 (21%) | 25 (23%) |  |
2012–2014 | 4 (29%) | 28 (25%) |  |
2015–2017 | 7 (50%) | 55 (5%) | 0.873 |
Karnosfky performance score | |||
100–90 | 3 (21%) | 52 (47%) |  |
80–70 | 6 (43%) | 41 (37%) |  |
 ≤ 60 | 4 (29%) | 13 (12%) |  |
Unknown | 1 (1%) | 5 (5%) | 0.122 |
Residual tumor | |||
Yes | 7 (50%) | 68 (61%) | Â |
No | 5 (36%) | 24 (22%) | Â |
Unknown | 2 (14%) | 19 (17%) | 0.512 |
Ø metastasis (mm) | 36.3 ± 7.7 | 29.5 ± 11.5 | 0.047* |